申请人:Bristol-Myers Squibb Company
公开号:US05401842A1
公开(公告)日:1995-03-28
The present invention provides physical admixtures of a new crystalline dihydrochloride dihydrate salt of the cephalosporin antibiotic, cefepime with a pharmaceutically acceptable non-toxic organic or inorganic base. In particular, this invention provides physical admixtures having a temperature and moisture stable crystalline dihydrochloride dihydrate form of cefepime having a specific X-ray powder diffraction pattern as described herein.
本发明提供了头孢噻肟的新晶体二盐酸盐二水合物与药学上可接受的无毒有机或无机碱的物理混合物。特别地,本发明提供了具有温度和湿度稳定的晶体二盐酸盐二水合物形式的头孢噻肟的物理混合物,其具有如下所述的特定X射线粉末衍射图案。